LOMAX MOBILITY LIMITED

1. Risk Rating: LOW The company presents a low overall risk profile. Lomax Mobility Limited operates as a non-trading holding company and is wholly owned by Sunrise Medical Limited (a corporate entity with >75% ownership). The company maintains positive net assets, has a long operational history (incorporated in 1997), and its filings are up to date. Its going concern status is explicitly supported by its parent group, and its primary underlying asset—a Chinese manufacturing subsidiary—was reported as profitable in the latest available detailed accounts.

2. Key Concerns * Reliance on Group Support: The company generates zero turnover and relies entirely on group support to manage future cash flows. The filed accounts explicitly state that going concern is dependent on an intercompany liability not being called within 12 months. While standard for a holding company, this means the entity cannot stand alone. * Limited Financial Visibility: The company utilizes small company exemptions, meaning detailed financial breakdowns are limited. Furthermore, the provided financial text only covers up to June 2019. While metadata indicates accounts have been filed up to June 2024, the specific financial position for recent years is not available in the provided data. * Jurisdictional and Operational Risk: The company's sole operating asset is an 80% stake in Xiamen Lomax Industrial Co Ltd in China. While profitable in the 2019 accounts, this concentrates risk in a single foreign jurisdiction, exposing the holding company to geopolitical, regulatory, and supply chain risks.

3. Positive Indicators * Strong Corporate Backing: The company is a wholly-owned subsidiary of Sunrise Medical Limited. This provides a corporate safety net regarding liquidity and solvency. * Profitable Underlying Asset: As of the 2019 accounts, the Chinese subsidiary (Xiamen Lomax) held net assets of approximately £4.36 million and generated a profit of roughly £563,000, indicating the holding company's core investment has intrinsic value. * Regulatory Compliance: The company is actively registered, filings are not overdue, and it has maintained a stable corporate structure for over 25 years.

4. Due Diligence Notes * Recent Financial Performance: It is necessary to obtain and review the full accounts up to the June 2024 period to verify the current valuation of the Chinese investment, assess current intercompany balances, and confirm ongoing profitability. * Parent Company Health: A full assessment of Lomax Mobility requires analyzing the financial statements of the ultimate parent, Sunrise Medical Limited, to ensure the group support mentioned in the going concern note is financially viable. * Subsidiary Control and Repatriation: Further investigation is required into the 80% ownership structure of the Chinese subsidiary, specifically regarding how profits are repatriated to the UK holding company and any foreign exchange controls that may impact liquidity.